APA (7th ed.) Citation

Ferri, L. E., Ades, S., Alcindor, T., Chasen, M., Marcus, V., Hickeson, M., . . . Thirlwell, M. P. (2012). Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: A multicenter phase II trial. Annals of Oncology, 23(6), 1512. https://doi.org/10.1093/annonc/mdr465

Chicago Style (17th ed.) Citation

Ferri, L. E., S. Ades, T. Alcindor, M. Chasen, V. Marcus, M. Hickeson, G. Artho, and M. P. Thirlwell. "Perioperative Docetaxel, Cisplatin, and 5-fluorouracil (DCF) for Locally Advanced Esophageal and Gastric Adenocarcinoma: A Multicenter Phase II Trial." Annals of Oncology 23, no. 6 (2012): 1512. https://doi.org/10.1093/annonc/mdr465.

MLA (9th ed.) Citation

Ferri, L. E., et al. "Perioperative Docetaxel, Cisplatin, and 5-fluorouracil (DCF) for Locally Advanced Esophageal and Gastric Adenocarcinoma: A Multicenter Phase II Trial." Annals of Oncology, vol. 23, no. 6, 2012, p. 1512, https://doi.org/10.1093/annonc/mdr465.